Skip to content
10-Q

Quarterly Report

Peak Bio, Inc.

0000950170-24-100213

← back to feed
Filed
Aug 23, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Aug 23, 2024 23.12M sh
Shares Diluted Q1 2024 · Mar 31, 2024 23.12M sh
Shares Diluted Q1 2024 · Mar 31, 2023 19.84M sh
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$1.42M
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$1.44M
Cash And Equivalents Q1 2024 · Mar 31, 2024 $68.61K
Cash And Equivalents Q1 2024 · Dec 31, 2023 $381.65K
Cash And Equivalents Q1 2024 · Mar 31, 2023 $564.18K
Stockholders Equity Q1 2024 · Mar 31, 2024 −$20.53M
Stockholders Equity Q1 2024 · Dec 31, 2023 −$18.16M
Stockholders Equity Q1 2024 · Mar 31, 2023 −$14.37M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$8.09M
Current Liabilities Q1 2024 · Mar 31, 2024 $22.28M
Current Liabilities Q1 2024 · Dec 31, 2023 $20.52M
Total Liabilities Q1 2024 · Mar 31, 2024 $22.28M
Total Liabilities Q1 2024 · Dec 31, 2023 $20.75M
Current Assets Q1 2024 · Mar 31, 2024 $1.56M
Current Assets Q1 2024 · Dec 31, 2023 $2.37M
Total Assets Q1 2024 · Mar 31, 2024 $1.75M
Total Assets Q1 2024 · Dec 31, 2023 $2.6M
Eps Diluted Q1 2024 · Mar 31, 2024 −$0.11
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.34
Eps Basic Q1 2024 · Mar 31, 2024 −$0.11
Eps Basic Q1 2024 · Mar 31, 2023 −$0.34
Sga Expense Q1 2024 · Mar 31, 2024 $2.13M
Sga Expense Q1 2024 · Mar 31, 2023 $3M
Rd Expense Q1 2024 · Mar 31, 2024 $70.27K
Rd Expense Q1 2024 · Mar 31, 2023 $713.11K
Net Income Q1 2024 · Mar 31, 2024 −$2.43M
Net Income Q1 2024 · Mar 31, 2023 −$6.77M
Operating Income Q1 2024 · Mar 31, 2024 −$2.2M
Operating Income Q1 2024 · Mar 31, 2023 −$7.22M
Revenue Q1 2024 · Mar 31, 2024 $0
Revenue Q1 2024 · Mar 31, 2023 $13.85K